{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:50:22Z","timestamp":1790779822714,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s12094-008-0170-4","type":"journal-article","created":{"date-parts":[[2008,4,10]],"date-time":"2008-04-10T11:46:11Z","timestamp":1207827971000},"page":"137-142","source":"Crossref","is-referenced-by-count":18,"title":["Uveal vs. cutaneous melanoma. Origins and causes of the differences"],"prefix":"10.1007","volume":"10","author":[{"given":"Carolina","family":"Belmar-Lopez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Mancheno-Corvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonia","family":"Saornil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Baril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Vassaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Quintanilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Martin-Duque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,4,11]]},"reference":[{"key":"170_CR1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jaad.2007.06.032","volume":"57","author":"A.C. Geller","year":"2007","unstructured":"Geller AC, Swetter SM, Brooks K et al (2007) Screening, early detection, and trends for melanoma: current status (2000\u20132006) and future directions. J Am Acad Dermatol 57:555\u2013576","journal-title":"J Am Acad Dermatol"},{"key":"170_CR2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/sj.jid.5701028","volume":"128","author":"A.M. Lachiewicz","year":"2008","unstructured":"Lachiewicz AM, Berwick M, Wiggins CL, Thomas NE (2008) Epidemiologic support for melanoma heterogeneity using the Surveillance, Epidemiology, and End Results Program. J Invest Dermatol 128:243\u2013245","journal-title":"J Invest Dermatol"},{"key":"170_CR3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ohc.2004.07.002","volume":"18","author":"A.D. Singh","year":"2005","unstructured":"Singh AD, Bergman L, Seregard S (2005) Uveal melanoma: epidemiologic aspects. Ophthalmol Clin N Am 18:75\u201384","journal-title":"Ophthalmol Clin N Am"},{"key":"170_CR4","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0161-6420(03)00078-2","volume":"110","author":"A.D. Singh","year":"2003","unstructured":"Singh AD, Topham A (2003) Incidence of uveal melanoma in the United States: 1973\u20131997. Ophthalmology 110:956\u2013961","journal-title":"Ophthalmology"},{"key":"170_CR5","first-page":"2579","volume":"43","author":"L. Bergman","year":"2002","unstructured":"Bergman L, Seregard S, Nilsson B et al (2002) Incidence of uveal melanoma in Sweden from 1960 to 1998. Invest Ophthalmol Vis Sci 43:2579\u20132583","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"170_CR6","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/archopht.1973.01000040468004","volume":"89","author":"J.A. Shields","year":"1973","unstructured":"Shields JA (1973) Lesions simulating malignant melanoma of the posterior uvea. Arch Ophthalmol 89:466\u2013471","journal-title":"Arch Ophthalmol"},{"key":"170_CR7","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.1990.01070110084030","volume":"108","author":"Collaborative Ocular Melanoma Study Group","year":"1990","unstructured":"Collaborative Ocular Melanoma Study Group (1990) Accuracy of diagnosis of choroidal melanomas in the COMS. COMS report no. 1. Arch Ophthalmol 108:1268\u20131273","journal-title":"Arch Ophthalmol"},{"key":"170_CR8","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1177\/107327480401100503","volume":"5","author":"D.J. Bell","year":"2004","unstructured":"Bell DJ, Wilson MW (2004) Choroidal melanoma: natural history and management options. Cancer Control 5:296\u2013301","journal-title":"Cancer Control"},{"key":"170_CR9","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1442-9071.2004.00917.x","volume":"32","author":"B. Damato","year":"2004","unstructured":"Damato B (2004) Developments in the management of uveal melanoma. Clin Exp Opthalmol 32:639\u2013647","journal-title":"Clin Exp Opthalmol"},{"key":"170_CR10","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/archopht.119.5.670","volume":"119","author":"COMS","year":"2001","unstructured":"COMS (2001) Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report no. 15. Arch Ophthalmol 119:670\u2013676","journal-title":"Arch Ophthalmol"},{"key":"170_CR11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0039-6257(91)90001-V","volume":"36","author":"J.A. Shields","year":"1991","unstructured":"Shields JA, Shields CL, Donoso LA (1991) Management of posterior uveal melanoma. Surv Ophthalmol 36:161\u2013195","journal-title":"Surv Ophthalmol"},{"key":"170_CR12","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/sj.eye.6702322","volume":"21","author":"S.A. Callejo","year":"2007","unstructured":"Callejo SA, Antecka E, Blanco PL et al (2007) Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study. Eye 21:752\u2013759","journal-title":"Eye"},{"key":"170_CR13","first-page":"59","volume":"286","author":"L. Croock De","year":"2002","unstructured":"De Croock L, Verbraeken H (2002) Metastatic uveal melanoma: diagnosis and treatment: a literature review. Bull Soc Belge Ophtalmol 286:59\u201363","journal-title":"Bull Soc Belge Ophtalmol"},{"key":"170_CR14","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1200\/JCO.2004.08.194","volume":"22","author":"M. Diener-West","year":"2004","unstructured":"Diener-West M, Reynolds SM, Agugliaro DJ et al (2004) Screening for metastasis from choroidal melanoma: the Collaborative Ocular Melanoma Study Group Report 23. J Clin Oncol 22:2438\u20132444","journal-title":"J Clin Oncol"},{"key":"170_CR15","unstructured":"Garc\u00eda-Alvarez C, Saornil MA, Mu\u00f1oz F et al (2007) Ocular conservation in 273 patients with uveal melanoma by a multimodality approach. European Association for Vision and Eye Research annual meeting. Abstract book:39"},{"key":"170_CR16","unstructured":"Saornil MA, Garc\u00eda-Alvarez C, Almaraz A et al (2007) Iodine-125 episcleral brachytherapy for uveal melanoma: 102 cases. Assessment. International Society of Ocular Oncology Meeting. Abstract book:333"},{"key":"170_CR17","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/j.ophtha.2007.01.032","volume":"114","author":"G. Virgili","year":"2007","unstructured":"Virgili G, Gatta G, Ciccolallo L et al; EUROCARE Working Group (2007) Incidence of uveal melanoma in Europe. Ophthalmology 114:2309\u20132315","journal-title":"Ophthalmology"},{"key":"170_CR18","first-page":"13","volume":"31","author":"M. Situm","year":"2007","unstructured":"Situm M, Buljan M, Buli\u00e6 SO, Simi\u00e6 D (2007) The mechanisms of UV radiation in the development of malignant melanoma. Coll Antropol 31:13\u201316","journal-title":"Coll Antropol"},{"key":"170_CR19","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.survophthal.2004.04.009","volume":"49","author":"A.D. Singh","year":"2004","unstructured":"Singh AD, Rennie IG, Seregard S et al (2004) Sunlight exposure and pathogenesis of uveal melanoma. Surv Ophthalmol 49:419\u2013428","journal-title":"Surv Ophthalmol"},{"key":"170_CR20","doi-asserted-by":"crossref","first-page":"6153","DOI":"10.1242\/dev.01533","volume":"131","author":"Y.M. Wilson","year":"2004","unstructured":"Wilson YM, Richards KL, Ford-Perriss ML et al (2004) Neural crest cell lineage segregation in the mouse neural tube. Development 131:6153\u20136162","journal-title":"Development"},{"key":"170_CR21","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1242\/dev.01106","volume":"131","author":"P.Y. Lwigale","year":"2004","unstructured":"Lwigale PY, Conrad GW, Bronner-Fraser M (2004) Graded potential of neural crest to form cornea, sensory neurons and cartilage along the rostrocaudal axis. Development 131:1979\u20131991","journal-title":"Development"},{"key":"170_CR22","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/00008390-200112000-00006","volume":"11","author":"M.H. Neale","year":"2001","unstructured":"Neale MH, Myatt NE, Khoury GG et al (2001) Comparison of the ex vivo chemosensitivity of uveal and cutaneous melanoma. Melanoma Res 11:601\u2013609","journal-title":"Melanoma Res"},{"key":"170_CR23","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/archopht.120.4.466","volume":"120","author":"S. Iwamoto","year":"2002","unstructured":"Iwamoto S, Burrows RC, Kalina RE et al (2002) Immunophenotypic differences between uveal and cutaneous melanomas. Arch Ophthalmol 120:466\u2013470","journal-title":"Arch Ophthalmol"},{"key":"170_CR24","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","volume":"3","author":"D. Bonnet","year":"1997","unstructured":"Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3:730\u2013737","journal-title":"Nat Med"},{"key":"170_CR25","first-page":"5821","volume":"63","author":"S.K. Singh","year":"2003","unstructured":"Singh SK, Clarke ID, Terasaki M et al (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63:5821\u20135828","journal-title":"Cancer Res"},{"key":"170_CR26","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M. Al-Hajj","year":"2003","unstructured":"Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100:3983\u20133988","journal-title":"Proc Natl Acad Sci USA"},{"key":"170_CR27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nature03128","volume":"432","author":"S. H. Singh","year":"2004","unstructured":"Singh SK HC, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB (2004) Identification of human brain tumour initiating cells. Nature 432:393\u2013401","journal-title":"Nature"},{"issue":"2","key":"170_CR28","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1582-4934.2006.tb00400.x","volume":"10","author":"S.V. Perryman","year":"2006","unstructured":"Perryman SV, Sylvester KG. (2006) Repair and regeneration: opportunities for carcinogenesis from tissue stem cells. J Cell Mol Med 10(2):292\u2013308. Review","journal-title":"J Cell Mol Med"},{"key":"170_CR29","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0002-9440(10)63431-1","volume":"165","author":"X. Borue","year":"2004","unstructured":"Borue X, Lee S, Grove J et al (2004) Bone marrow-derived cells contribute to epithelial engraftment during wound healing. Am J Pathol 165:1767\u20131772Borue X, Lee S, Grove J et al (2004) Bone marrow-derived cells contribute to epithelial engraftment during wound healing. Am J Pathol 165:1767\u20131772","journal-title":"Am J Pathol"},{"key":"170_CR30","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1126\/science.1099513","volume":"306","author":"J. Houghton","year":"2004","unstructured":"Houghton J, Stoicov C, Nomura S et al (2004) Gastric cancer originating from bone marrow-derived cells. Science 306:1568\u20131571","journal-title":"Science"},{"key":"170_CR31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","volume":"414","author":"T. Reya","year":"2001","unstructured":"Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414:105\u2013111","journal-title":"Nature"},{"key":"170_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.0022-202x.2001.00006.x","volume":"6","author":"H. Yoshida","year":"2001","unstructured":"Yoshida H, Kunisada T, Grimm T et al (2001) Melanocyte migration and survival controlled by SCF\/c-kit expression. J Invest Dermatol Symp Proc 6:1\u20135","journal-title":"J Invest Dermatol Symp Proc"},{"key":"170_CR33","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/332411a0","volume":"332","author":"M. Yanagisawa","year":"1988","unstructured":"Yanagisawa M, Kurihara H, Kimura S et al (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411\u2013415","journal-title":"Nature"},{"key":"170_CR34","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1038\/sj.onc.1206460","volume":"22","author":"E. Dupin","year":"2003","unstructured":"Dupin E, Le Dourain NM (2003) Development of melanocyte precursors from the vertebrate neural crest. Oncogene 22:3016\u20133023","journal-title":"Oncogene"},{"key":"170_CR35","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1101\/gad.14.2.158","volume":"14","author":"R.I. Dorski","year":"2000","unstructured":"Dorski RI, Daible DW, Moon RT (2000) Direct regulation of nacre, a zebrafish MITF homolog required for pigment cell formation, by the Wnt pathway. Genes Dev 14:158\u2013162","journal-title":"Genes Dev"},{"key":"170_CR36","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/24620","volume":"396","author":"R.I. Dorsky","year":"1998","unstructured":"Dorsky RI, Moon RT, Raible DV (1998) Control of neural crest cell fate by the Wnt signalling pathway. Nature 396:370\u2013373","journal-title":"Nature"},{"key":"170_CR37","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1634\/stemcells.2005-0414","volume":"24","author":"D. Fang","year":"2006","unstructured":"Fang D, Leishear K, Nguyen TK et al (2006) Defining the conditions for the generation of melanocytes from human embryonic stem cells. Stem Cells 24:1668\u20131677","journal-title":"Stem Cells"},{"key":"170_CR38","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/jcb.21204","volume":"101","author":"J.T. Lee","year":"2007","unstructured":"Lee JT, Herlyn M (2007) Microenvironmental influences in melanoma progression. J Cell Biochem 101:862\u2013872","journal-title":"J Cell Biochem"},{"key":"170_CR39","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nrc2108","volume":"7","author":"M.J.C. Hendrix","year":"2007","unstructured":"Hendrix MJC, Seftor EA, Seftor REB et al (2007) Reprogramming metastatic tumour cells with embryonic microenvironments. Nat Rev Cancer 7:246\u2013255","journal-title":"Nat Rev Cancer"},{"key":"170_CR40","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/416854a","volume":"416","author":"E.K. Nishimura","year":"2002","unstructured":"Nishimura EK, Jordan SA, Oshima H et al (2002) Dominant role of the niche in melanocyte stem-cell fate determination. Nature 416:854\u2013860","journal-title":"Nature"},{"key":"170_CR41","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2353\/ajpath.2006.051170","volume":"168","author":"H. Yu","year":"2006","unstructured":"Yu H, Fang D, Kumar SM et al (2006) Isolation of a novel population of multipotent adult stem cells from human hair follicles. Am J Pathol 168:1879\u20131888","journal-title":"Am J Pathol"},{"key":"170_CR42","doi-asserted-by":"crossref","first-page":"9328","DOI":"10.1158\/0008-5472.CAN-05-1343","volume":"65","author":"D. Fang","year":"2005","unstructured":"Fang D, Nguyen TK, Leishear K et al (2005) Tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 65:9328\u20139337","journal-title":"Cancer Res"},{"key":"170_CR43","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/35020115","volume":"406","author":"M. Bittner","year":"2000","unstructured":"Bittner M, Meltzer P, Chen Y et al (2000) Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406:536\u2013540","journal-title":"Nature"},{"key":"170_CR44","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature06489","volume":"451","author":"T. Schatton","year":"2008","unstructured":"Schatton T, Murphy GF, Frank NY et al (2008) Identification of cells initiating human melanomas. Nature 451:345\u2013358","journal-title":"Nature"},{"key":"170_CR45","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-1-4684-4394-3_6","volume":"155","author":"R.T. Prehn","year":"1982","unstructured":"Prehn RT (1982) Immunological surveillance versus immunological stimulation of oncogenesis \u2014 a formal proof of the stimulation hypothesis. Adv Exp Med Biol 155:77\u201385","journal-title":"Adv Exp Med Biol"},{"key":"170_CR46","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/j.1600-0463.2007.apm_855.xml.x","volume":"115","author":"C. Dahl","year":"2007","unstructured":"Dahl C, Guldberg P (2007) The genome and epigenome of malignant melanoma. APMIS 115:1161\u20131176. Review","journal-title":"APMIS"},{"key":"170_CR47","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H. Davies","year":"2002","unstructured":"Davies H, Bignell GR, Cox C et al (2002) Mutations of the BRAF gene in human cancer. Nature 417:949\u2013954","journal-title":"Nature"},{"key":"170_CR48","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.canlet.2004.06.049","volume":"214","author":"M. Rodolfo","year":"2004","unstructured":"Rodolfo M, Daniotti M, Vallacchi V (2004) Genetic progression of metastatic melanoma. Cancer Lett 214:133\u2013147. Review","journal-title":"Cancer Lett"},{"key":"170_CR49","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrc1819","volume":"6","author":"M. Cully","year":"2006","unstructured":"Cully M, You H, Levine AJ, Mak TW (2006) Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer 6:184\u2013192. Review","journal-title":"Nat Rev Cancer"},{"key":"170_CR50","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.canlet.2005.11.042","volume":"241","author":"L.M. Chow","year":"2006","unstructured":"Chow LM, Baker SJ (2006) PTEN function in normal and neoplastic growth. Cancer Lett 241:184\u2013196. Review","journal-title":"Cancer Lett"},{"key":"170_CR51","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/gcc.2870080307","volume":"8","author":"K. Isshiki","year":"1993","unstructured":"Isshiki K, Elder DE, Guerry D, Linnenbach AJ (1993) Chromosome 10 allelic loss in malignant melanoma. Genes Chromosomes Cancer 8:178\u2013184","journal-title":"Genes Chromosomes Cancer"},{"key":"170_CR52","doi-asserted-by":"crossref","first-page":"10879","DOI":"10.1158\/0008-5472.CAN-07-2564","volume":"67","author":"C. Segrelles","year":"2007","unstructured":"Segrelles C, Lu J, Hammann B et al (2007) Deregulated activity of Akt in epithelial basal cells induces spontaneous tumors and heightened sensitivity to skin carcinogenesis. Cancer Res 67:10879\u201310888","journal-title":"Cancer Res"},{"key":"170_CR53","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1038\/sj.onc.1210009","volume":"26","author":"P. Baril","year":"2007","unstructured":"Baril P, Gangeswaran R, Mahon PC et al (2007) Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta4 integrin and the PI3k pathway. Oncogene 26:2082\u20132094","journal-title":"Oncogene"},{"key":"170_CR54","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/ng0994-15","volume":"8","author":"C.J. Hussussian","year":"1994","unstructured":"Hussussian CJ, Struewing JP, Goldstein AM et al (1994) Germline p16 mutations in familial melanoma. Nat Genet 8:15\u201321","journal-title":"Nat Genet"},{"key":"170_CR55","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1158\/1078-0432.CCR-07-1825","volume":"14","author":"J.P. Ehlers","year":"2008","unstructured":"Ehlers JP, Worley L, Onken MD, Harbour JW (2008) Integrative genomic analysis of aneuploidy in uveal melanoma. Clin Cancer Res 14:115\u2013122","journal-title":"Clin Cancer Res"},{"key":"170_CR56","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ctrv.2005.05.001","volume":"31","author":"L.G. Baggetto","year":"2005","unstructured":"Baggetto LG, Gambrelle J, Dayan G et al (2005) Major cytogenetic aberrations and typical multidrug resistance phenotype of uveal melanoma: current views and new therapeutic prospects. Cancer Treat Rev 31:361\u2013379. Review","journal-title":"Cancer Treat Rev"},{"key":"170_CR57","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/09273940490518586","volume":"13","author":"J.Y. Niederkorn","year":"2005","unstructured":"Niederkorn JY, Wang S (2005) Immunology of intraocular tumors. Ocul Immunol Inflamm 13:105\u2013110","journal-title":"Ocul Immunol Inflamm"},{"key":"170_CR58","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1582-4934.2007.00088.x","volume":"11","author":"M. Mimeault","year":"2007","unstructured":"Mimeault M, Hauke R, Mehta PP, Batra SK (2007) Recent advances in cancer stem\/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers. J Cell Mol Med 11:981\u20131011","journal-title":"J Cell Mol Med"},{"key":"170_CR59","doi-asserted-by":"crossref","unstructured":"Simka M (2008) Do nonmelanoma skin cancers develop from extra-cutaneous stem cells? Int J Cancer Epub ahead of printing Jan 31","DOI":"10.1002\/ijc.23373"},{"key":"170_CR60","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00008390-200508000-00005","volume":"15","author":"S. Labialle","year":"2005","unstructured":"Labialle S, Dayan G, Gambrelle J et al (2005) Characterization of the typical multidrug resistance profile in human uveal melanoma cell lines and in mouse liver metastasis derivatives. Melanoma Res 15:257\u2013266","journal-title":"Melanoma Res"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-008-0170-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-008-0170-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-008-0170-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T15:42:19Z","timestamp":1684338139000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-008-0170-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["170"],"URL":"https:\/\/doi.org\/10.1007\/s12094-008-0170-4","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}